Lipke Michael, Sundaram Chandru P
Department of Urology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
J Minim Access Surg. 2005 Oct;1(4):196-201. doi: 10.4103/0972-9941.19267.
Millions of men are diagnosed annually with prostate cancer worldwide. With the advent of PSA screening, there has been a shift in the detection of early prostate cancer, and there are increased numbers of men with asymptomatic, organ confined disease. Laparoscopic radical prostatectomy is the latest, well accepted treatment that patients can select. We review the surgical technique, and oncologic and functional outcomes of the most current, large series of laparoscopic radical prostatectomy published in English.Positive margin rates range from 2.1-6.9% for pT2a, 9.9-20.6% for pT2b, 24.5-42.3% for pT3a, and 22.6-54.5% for pT3b. Potency rates after bilateral nerve sparing laparoscopic radical prostatectomy range from 47.1 to 67%. Continence rates at 12 months range from 83.6 to 92%.
全球每年有数百万人被诊断出患有前列腺癌。随着前列腺特异性抗原（PSA）筛查的出现，早期前列腺癌的检测方式发生了转变，无症状、局限于器官的疾病患者数量有所增加。腹腔镜根治性前列腺切除术是患者可以选择的最新且被广泛接受的治疗方法。我们回顾了以英文发表的关于当前最大系列腹腔镜根治性前列腺切除术的手术技术、肿瘤学和功能结果。pT2a期的切缘阳性率为2.1% - 6.9%，pT2b期为9.9% - 20.6%，pT3a期为24.5% - 42.3%，pT3b期为22.6% - 54.5%。双侧神经保留腹腔镜根治性前列腺切除术后的性功能恢复率为47.1%至67%。12个月时的控尿率为83.6%至92%。
